TY - JOUR T1 - MAO inhibitors: Risks, benefits, and lore JF - Cleveland Clinic Journal of Medicine JO - Cleve Clin J Med SP - 859 LP - 882 DO - 10.3949/ccjm.77a.09103 VL - 77 IS - 12 AU - Molly Wimbiscus AU - Olga Kostenko AU - Donald Malone Y1 - 2010/12/01 UR - http://www.ccjm.org/content/77/12/859.abstract N2 - Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents. However, interest in MAO inhibitors is reviving. Here, we discuss their use, risks, and benefits in clinical medicine. ER -